{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:48:09Z","timestamp":1791503289229,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000072","name":"U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["DE025030"],"award-info":[{"award-number":["DE025030"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Non-obese Diabetic (NOD) mouse model for type I diabetes also develops some features of Sj\u00f6gren\u2019s syndrome (SS). Since the source of the mice and the environment exert a strong influence on diabetes, this study investigated SS development in NOD mice obtained from two vendors. Female NOD mice from The Jackson Laboratory (JAX) and Taconic Biosciences were monitored for blood glucose and pilocarpine-induced salivation. The gut microbiome was analyzed by 16S rRNA sequencing of stool DNA. At euthanasia, serum cytokines and sialoadenitis severity were evaluated. The onset of diabetes was significantly accelerated in JAX mice compared to Taconic mice. Although the gut microbiome between the two groups was distinct, both groups developed sialoadenitis. There was no correlation between the severity of sialoadenitis and reduced saliva production. Instead, salivary gland dysfunction was associated with hyperglycemia and elevation of serum IL1\u03b2, IL16, and CXCL13. Our data suggest that inflammatory pathways linked with hyperglycemia are confounding factors for salivary gland dysfunction in female NOD mice, and might not be representative of the mechanisms operative in SS patients. Considering that NOD mice have been used to test numerous experimental therapies for SS, caution needs to be exerted before advancing these therapeutics for human trials.<\/jats:p>","DOI":"10.1038\/s41598-019-54410-9","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T11:03:10Z","timestamp":1575025390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Hyperglycemia and Salivary Gland Dysfunction in the Non-obese Diabetic Mouse: Caveats for Preclinical Studies in Sj\u00f6gren\u2019s Syndrome"],"prefix":"10.1038","volume":"9","author":[{"given":"Bujana","family":"Allushi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harini","family":"Bagavant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Papinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh S.","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"key":"54410_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.clim.2019.04.009","volume":"203","author":"FB Vivino","year":"2019","unstructured":"Vivino, F. B. et al. Sjogren\u2019s syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clin. Immunol. 203, 81\u2013121 (2019).","journal-title":"Clin. Immunol."},{"key":"54410_CR2","first-page":"209","volume":"37","author":"F Xiao","year":"2019","unstructured":"Xiao, F. et al. Animal models of Sjogren\u2019s syndrome: an update. Clin. Exp. Rheumatol. 37, 209\u2013216 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"54410_CR3","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.1233521","volume":"339","author":"JG Markle","year":"2013","unstructured":"Markle, J. G. et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 339, 1084\u20131088 (2013).","journal-title":"Science."},{"key":"54410_CR4","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1136\/gutjnl-2017-314508","volume":"67","author":"A Hanninen","year":"2018","unstructured":"Hanninen, A. et al. Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice. Gut. 67, 1445\u20131453 (2018).","journal-title":"Gut."},{"key":"54410_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13075-019-1904-0","volume":"21","author":"JW Kim","year":"2019","unstructured":"Kim, J. W. et al. Metformin improves salivary gland inflammation and hypofunction in murine Sjogren\u2019s syndrome. Arthritis. Res. Ther. 21, 136, https:\/\/doi.org\/10.1186\/s13075-019-1904-0 (2019).","journal-title":"Arthritis. Res. Ther."},{"key":"54410_CR6","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/annrheumdis-2018-213929","volume":"78","author":"G Wieczorek","year":"2019","unstructured":"Wieczorek, G. et al. Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD\/ShiLtJ mouse model of Sjogren\u2019s syndrome. Ann. Rheum. Dis. 78, 974\u2013978 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"54410_CR7","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1053\/j.gastro.2017.06.011","volume":"153","author":"M Zeng","year":"2017","unstructured":"Zeng, M. et al. Restoration of CFTR Activity in Ducts Rescues Acinar Cell Function and Reduces Inflammation in Pancreatic and Salivary Glands of Mice. Gastroenterol. 153, 1148\u20131159 (2017).","journal-title":"Gastroenterol."},{"key":"54410_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/srep45525","volume":"7","author":"CS Wang","year":"2017","unstructured":"Wang, C. S., Maruyama, C. L., Easley, J. T., Trump, B. G. & Baker, O. J. AT-RvD1 Promotes Resolution of Inflammation in NOD\/ShiLtJ mice. Sci. Rep. 7, 45525, https:\/\/doi.org\/10.1038\/srep45525 (2017).","journal-title":"Sci. Rep."},{"key":"54410_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/srep39105","volume":"6","author":"J Zhou","year":"2016","unstructured":"Zhou, J., Jin, J. O., Kawai, T. & Yu, Q. Endogenous programmed death ligand-1 restrains the development and onset of Sjgren\u2019s syndrome in non-obese diabetic mice. Sci. Rep. 6, 39105, https:\/\/doi.org\/10.1038\/srep39105 (2016).","journal-title":"Sci. Rep."},{"key":"54410_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3164\/jcbn.16-31","volume":"59","author":"H Inoue","year":"2016","unstructured":"Inoue, H. et al. Resveratrol improves salivary dysfunction in a non-obese diabetic (NOD) mouse model of Sjogren\u2019s syndrome. J. Clin. Biochem. Nutr. 59, 107\u2013112 (2016).","journal-title":"J. Clin. Biochem. Nutr."},{"key":"54410_CR11","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/ard.2006.064030","volume":"66","author":"SD Tran","year":"2007","unstructured":"Tran, S. D. et al. Reversal of Sjogren\u2019s-like syndrome in non-obese diabetic mice. Ann. Rheum. Dis. 66, 812\u2013814 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"54410_CR12","doi-asserted-by":"publisher","unstructured":"Bagavant, H., et al. A Method for the Measurement of Salivary Gland Function in Mice. Journal of visualized experiments. J. Vis. Exp. 131, https:\/\/doi.org\/10.3791\/57203 (2018).","DOI":"10.3791\/57203"},{"key":"54410_CR13","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1002\/art.21945","volume":"54","author":"MV Jonsson","year":"2006","unstructured":"Jonsson, M. V., Delaleu, N., Brokstad, K. A., Berggreen, E. & Skarstein, K. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland. Arthritis Rheum. 54, 2300\u20132305 (2006).","journal-title":"Arthritis Rheum."},{"key":"54410_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fendo.2019.00056","volume":"10","author":"MJL Verhulst","year":"2019","unstructured":"Verhulst, M. J. L., Loos, B. G., Gerdes, V. E. A. & Teeuw, W. J. Evaluating All Potential Oral Complications of Diabetes Mellitus. Front. Endocrinol. 10, 56, https:\/\/doi.org\/10.3389\/fendo.2019.00056 (2019).","journal-title":"Front. Endocrinol."},{"key":"54410_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1172\/JCI4431","volume":"103","author":"J Wang","year":"1999","unstructured":"Wang, J. et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J. Clin. Invest. 103, 27\u201337 (1999).","journal-title":"J. Clin. Invest."},{"key":"54410_CR16","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/labinvest.2012.60","volume":"92","author":"CK Yeh","year":"2012","unstructured":"Yeh, C. K. et al. Hyperglycemia and xerostomia are key determinants of tooth decay in type 1 diabetic mice. Lab. Invest. 92, 868\u2013882 (2012).","journal-title":"Lab. Invest."},{"key":"54410_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bbadis.2005.12.002","volume":"1762","author":"NV Fedirko","year":"2006","unstructured":"Fedirko, N. V. et al. Changes in functioning of rat submandibular salivary gland under streptozotocin-induced diabetes are associated with alterations of Ca2+ signaling and Ca2+ transporting pumps. Biochim. Biophys. Acta. 1762, 294\u2013303 (2006).","journal-title":"Biochim. Biophys. Acta."},{"key":"54410_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.0300-9475.2004.01508.x","volume":"60","author":"S Cha","year":"2004","unstructured":"Cha, S. et al. A dual role for interferon-gamma in the pathogenesis of Sjogren\u2019s syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand. J. Immunol. 60, 552\u2013565 (2004).","journal-title":"Scand. J. Immunol."},{"key":"54410_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10067-015-3072-1","volume":"35","author":"KL Augusto","year":"2016","unstructured":"Augusto, K. L. et al. Metabolic syndrome in Sjogren\u2019s syndrome patients: a relevant concern for clinical monitoring. Clin. Rheumatol. 35, 639\u2013647 (2016).","journal-title":"Clin. Rheumatol."},{"key":"54410_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1601-0825.2011.01852.x","volume":"18","author":"N Roescher","year":"2012","unstructured":"Roescher, N. et al. Temporal changes in salivary glands of non-obese diabetic mice as a model for Sj\u00f6gren\u2019s syndrome. Oral Dis. 18, 96\u2013106 (2012).","journal-title":"Oral Dis."},{"key":"54410_CR21","doi-asserted-by":"publisher","unstructured":"Zhou, J., Jin, J. O., Kawai, T. & Yu, Q. Endogenous programmed death ligand-1 restrains the development and onset of Sj\u04e7gren\u2019s syndrome in non-obese diabetic mice. Sci. Rep. 6, https:\/\/doi.org\/10.1038\/srep39105 (2016).","DOI":"10.1038\/srep39105"},{"key":"54410_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/imm.12948","volume":"155","author":"JY Barr","year":"2018","unstructured":"Barr, J. Y., Wang, X., Kreiger, P. A. & Lieberman, S. M. Salivary-gland-protective regulatory T-cell dysfunction underlies female-specific sialadenitis in the non-obese diabetic mouse model of Sj\u00f6gren syndrome. Immunology. 155, 225\u2013237 (2018).","journal-title":"Immunology."},{"key":"54410_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ai.2014.11.001","volume":"126","author":"H Braley-Mullen","year":"2015","unstructured":"Braley-Mullen, H. & Yu, S. NOD.H-2h4 mice: an important and underutilized animal model of autoimmune thyroiditis and Sjogren\u2019s syndrome. Adv. Immunol. 126, 1\u201343 (2015).","journal-title":"Adv. Immunol."},{"key":"54410_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.clim.2017.04.009","volume":"183","author":"J Kiripolsky","year":"2017","unstructured":"Kiripolsky, J. et al. Systemic manifestations of primary Sjogren\u2019s syndrome in the NOD.B10Sn-H2(b)\/J mouse model. Clin. Immunol. 183, 225\u2013232 (2017).","journal-title":"Clin. Immunol."},{"key":"54410_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/annrheumdis-2014-206297","volume":"75","author":"BM Szczerba","year":"2016","unstructured":"Szczerba, B. M. et al. Interaction between innate immunity and Ro52-induced antibody causes Sjogren\u2019s syndrome-like disorder in mice. Ann. Rheum. Dis. 75, 617\u201322 (2016).","journal-title":"Ann. Rheum. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54410-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54410-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54410-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T16:40:21Z","timestamp":1671295221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54410-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["54410"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-54410-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]},"assertion":[{"value":"2 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17969"}}